AbbVie is a global biopharmaceutical company dedicated to advancing medical research and delivering innovative treatments to address serious health issues. Founded as a spin-off from Abbott Laboratories in 2013, AbbVie has established itself as a leader in several therapeutic areas, including immunology, oncology, neuroscience, eye care, and aesthetics through its Allergan portfolio. The company’s mission is to help people live healthier lives by developing groundbreaking therapies, with a strong focus on biologics, small molecules, and combination treatments. AbbVie is committed to addressing unmet medical needs and driving transformative science, working closely with healthcare professionals, researchers, and patients. Notable achievements include its leadership in immunology with blockbuster drugs like Humira, and recent advancements in oncology with therapies for various cancers.